Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;60(3):268-275.
doi: 10.1007/s12275-022-2037-8. Epub 2022 Mar 2.

Protective and pathogenic role of humoral responses in COVID-19

Uni Park  1   2 , Nam-Hyuk Cho  3   4   5   6   7
Affiliations
Review

Protective and pathogenic role of humoral responses in COVID-19

Uni Park et al. J Microbiol. 2022 Mar.

Erratum in

Abstract

Since the advent of SARS-CoV-2 in Dec. 2019, the global endeavor to identify the pathogenic mechanism of COVID-19 has been ongoing. Although humoral immunity including neutralizing activity play an important role in protection from the viral pathogen, dysregulated antibody responses may be associated with the pathogenic progression of COVID-19, especially in high-risk individuals. In addition, SARS-CoV-2 spike-specific antibodies acquired by prior infection or vaccination act as immune pressure, driving continuous population turnover by selecting for antibody-escaping mutations. Here, we review accumulating knowledge on the potential role of humoral immune responses in COVID-19, primarily focusing on their beneficial and pathogenic properties. Understanding the multifaceted regulatory mechanisms of humoral responses during SARS-CoV-2 infection can help us to develop more effective therapeutics, as well as protective measures against the ongoing pandemic.

Keywords: COVID-19; SARS-CoV-2; antibody-escaping variants; humoral immunity.

PubMed Disclaimer

References

    1. Abdulrahman A, Mallah SI, Alqahtani M. COVID- 19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect. Dis. 2021;21:688. doi: 10.1186/s12879-021-06376-1. - DOI - PMC - PubMed
    1. Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat. Rev. Immunol. 2022;22:77–84. doi: 10.1038/s41577-021-00665-1. - DOI - PMC - PubMed
    1. Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, et al. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg. Microbes Infect. 2022;11:337–343. doi: 10.1080/22221751.2021.2022440. - DOI - PMC - PubMed
    1. Anand SP, Prévost J, Nayrac M, Beaudoin-Bussières G, Benlarbi M, Gasser R, Brassard N, Laumaea A, Gong SY, Bourassa C, et al. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep. Med. 2021;2:100290. doi: 10.1016/j.xcrm.2021.100290. - DOI - PMC - PubMed
    1. Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Göppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, et al. Circulating immune complexes drive immunopathology in COVID-19. 2021. - PMC - PubMed

Substances